Sarah Bernstein

A Phase I Vaccine Trial with Peptides Reflecting ras Oncogene Mutations of Solid Tumors

Samir N. Khleif, Scott I. Abrams, J. Michael Hamilton et al. · Journal of Immunotherapy · 1999 · 123 citations

Medicine, Immunology, Oncology +16

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers

Antoun Toubaji, M. S. Achtar, Maurizio Provenzano et al. · Cancer Immunology Immunotherapy · 2008 · 120 citations · Full text

Medicine, Immunology, Oncology +17

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Osama E. Rahma, Ed Ashtar, Malgorzata Czystowska et al. · Cancer Immunology Immunotherapy · 2011 · 101 citations

Medicine, Immunology, Oncology +16

Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer

Chad A. Hamilton, G. Larry Maxwell, Mildred R. Chernofsky et al. · Gynecologic Oncology · 2008 · 86 citations

Medicine, Gynecology, Oncology +11

The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors

Osama E. Rahma, J. Michael Hamilton, Małgorzata Wójtowicz et al. · Journal of Translational Medicine · 2014 · 66 citations · Full text

Medicine, Immunology, Oncology +17